Abstract:Objective To analysis the modified Gleason scoring system for predicting the prognosis after radical prostatectomy.Methods A total of 242 patients who received radical prostatectomy from April,2006 to October 2011 were recruited.The patients who lost follow-up or had adjuvant radiation or hormonal therapy or had visceral or bone metastasis were excluded,the remaining 168 patients were evaluated in the present study.The patients' age ranged from 53 to 85 years old (mean age 69 years old).The mean PSA level was 13.31ng/ml (ranging from 4.59 to 36.12 ng/ml).According to the traditional Gleason scoring system,there were 50 patients in Gleason ≤ 6 group,86 patients in Gleason 7 group and 32 patients in Gleason≥8 group.Patients were divided in five groups according to the modified Gleason scoring system.There were 50 patients in Gleason ≤6 group,67 in Gleason 3 + 4 group,19 in Gleason 4 + 3 group,15 in Gleason 8 group and 17 in Gleason 9-10 group.The biochemical-free-survival curve was drawn by Kaplan-Meier method and the multivariate Cox regression models were used to evaluate the clinical and pathological variables for the development of biochemical recurrence.ROC curve analysis was used to determine the predicted value for 5-year BCR of modified and traditional Gleason scoring.Results Significant differences were noted between the modified Gleason scoring groups and traditional Gleason scoring groups in PSA value (P =0.005),pathological stage (P =0.002),extraprostatic extension (P =0.003),seminal vesicle invasion (P =0.004),lymph node involvement (P =0.049) and positive surgical margin (P =0.006).With a median follow-up of 68 months(ranging from 7 to 98 months),5-year BFS rates for men with Gleason grade ≤6,3 + 4,4 + 3,8 and 9-10 tumours on RP pathology were 84.0％ (42/50),76.1％ (51/67),57.9％(11/19),40.0％ (9/15),29.4％ (5/17),respectively.On multivariate analysis,the HR value of Gleason 3 + 4 group and Gleason 4 + 3 group were 1.736 and 2.075 (P ＜ 0.05).The area under the curve in modified and traditional Gleason scoring were 0.698 (95％ CI 0.609-0.788) and 0.674 (95％ CI O.584-0.764),respectively.Conclusions The modified Gleason scoring system is related to the prostate cancer grade and its survival rate.Therefore,it can predict prognosis accurately in patients with prostate cancer.It can potential to reduce overtreatment in patients with Gleason 3 +4 prostate cancer.

Upgrade in Gleason Score Between Biopsy and Radical Prostatectomy Pathology Indicates Poor Outcomes in Prostate Cancer

Does the Gleason Score 7 Upgrading Always Predict Worse Prognosis?

[Clinically Predictive Factors of Gleason Score Upgrading in Patients after Radical Prostatectomy].

[Influence of Clinical Factors on Gleason Score Upgrade in Patients Undergoing Radical Prostatectomy].

Predictive Factors for Gleason Score Upgrading in Patients with Prostate Cancer after Radical Prostatectomy: A Systematic Review and Meta- Analysis

Prognostic Significance of Modified Gleason Scoring System after Radical Prostatectomy

Comparing Histology Between Prostate Cognitive Fusion Targeted Biopsy and Radical Prostatectomy: Exploring Risk Factors of Gleason Score Upgrading in Chinese Patients.

Factors Predicting 2014 ISUP Pathology Grade Upgrading from Prostate Biopsy to Radical Prostatectomy Pathology

Risk factors of Gleason score upgrade in patients undergone radical prostatectomy

Predictive risk factor for Gleason score upgrading in low risk prostate cancer after radical prostatectomy

Predictors of Gleason Grading Group Upgrading in Low-Risk Prostate Cancer Patients From Transperineal Biopsy After Radical Prostatectomy

Nomograms for Predicting Gleason Upgrading in a Contemporary Chinese Cohort Receiving Radical Prostatectomy after Extended Prostate Biopsy: Development and Internal Validation

The Changes in Gleason Score Between the Diagnostic Biopsy and Radical Prostatectomy Pathology

Predictive Factors for Clinically Significant Elevation of Post-Prostatectomy Gleason Score in Patients with Biopsy Gleason Score ≤7

Value of Prostate-Specific Antigen Density in Predicting an Upgrade in Gleason Score for Initial Prostate Biopsy

Pathological upgrading at radical prostatectomy for patients with Grade Group 1 prostate cancer: implications of confirmatory testing for patients considering active surveillance

CRMP4 CpG Hypermethylation Predicts Upgrading to Gleason Score ≥ 8 in Prostate Cancer

Management of prostate cancer patients with locally adverse pathologic features after radical prostatectomy: feasibility of active surveillance for cases with Gleason grade 3 + 4 = 7

Prostate Cancer Gleason Score From Biopsy to Radical Surgery: Can Ultrasound Shear Wave Elastography and Multiparametric Magnetic Resonance Imaging Narrow the Gap?

Prognostic Models for Patients with Gleason Score 9 Prostate Cancer: A Population-Based Study.

Gleason Sum Upgrading Between Biopsy and Radical Prostatectomy in Chinese Population: Updated Nomograms.